Plasma exchange for the treatment of human T-cell lymphotropic virus type 1 associated myelopathy

Therapeutic Apheresis

Volumn 5, Issue 6, 2001, Pages 491-493

  Narukawa, Nobuhiko ^a   Shiizaki, Kazuhiro ^a   Kitabata, Yukiko ^a   Abe, Takaya ^a   Kobata, Hirotsugu ^a   Akizawa, Tadao ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Human T cell lymphotropic virus type 1 associated myelopathy; Plasma exchange

Indexed keywords

ALPHA INTERFERON; ASCORBIC ACID; CORTICOSTEROID; ERYTHROMYCIN; FOSFOMYCIN; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; CYSTOMETRY; DISEASE COURSE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; LUNG TUBERCULOSIS; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; SPINAL CORD DISEASE; URINE RETENTION;

HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; PLASMA EXCHANGE; TUBERCULOSIS, PULMONARY;

EID: 0035673976     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2001.00398.x     Document Type: Article

References (7)

1. An autoaggressive process against bystander tissues in HTLV-1 infected individuals: A possible pathomechanism of HAM/TSP
2. HTLV-1-associated myelopathy (HAM/TSP)
3. HTLV-1-associated myelopathy: Analysis of 213 patients based on clinical features and laboratory findings
4. New strategy on treatment of HAM/TSP
5. Therapeutic trials in 200 patients with HTLV-1-associated myelopathy/tropical spastic paraparesis
6. HTLV-1 associated myelopathy: Diagnosis and therapy
7. Long-term follow up of immunomodulation in treatment of HTLV-1-associated myelopathy